Giulio Maria Gadda

Vita-Salute San Raffaele University

Papers

3

Total Citations

130

H-Index

2

About

Giulio Maria Gadda is a urologic surgeon and researcher whose work centers on improving outcomes in prostate cancer diagnosis and treatment, with a particular focus on precision biomarkers and minimally invasive surgical techniques. His most influential contribution comes from a landmark 2011 study on the prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and the Prostate Health Index. This work, cited over 120 times, demonstrated that these novel biomarkers could predict pathologic outcomes in patients undergoing radical prostatectomy, offering a more accurate tool for risk stratification than traditional PSA testing alone. Gadda has also been at the forefront of surgical innovation, contributing to the development of robotic laparoendoscopic single-site (r-LESS) radical prostatectomy as part of the IDEAL framework for surgical innovation. Additionally, his comparative studies on nerve-sparing techniques have helped clarify factors influencing erectile function recovery after open versus robotic prostatectomy. Through his integration of advanced biomarkers and surgical refinement, Gadda has advanced the goal of more personalized, function-preserving care for prostate cancer patients.

Research Focus

Key Achievements

2
H-Index
3
Papers
130
Total Citations
43
Avg Citations/Paper
🏆 Most Cited Paper
Preoperative Prostate-Specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer
124 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 24
🏛 Institutions: Vita-Salute San Raffaele University

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago